ArticleActa physiologica (Oxford, England)2026
Reduced Expression of Magnesium Transport Proteins in the Distal Convoluted Tubule of Clcnkb-Deficient Mice May Explain Urinary Magnesium Wasting in Classical Bartter Syndrome.
Article in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
aimThe kidney thick ascending limb (TAL) plays a key role in the transport of sodium, chloride, potassium, calcium, and magnesium. Bartter syndrome is a hypokalemic, salt-losing tubulopathy caused by impaired TAL function. Pathogenic variants in SLC12A1 or KCNJ1 cause antenatal Bartter syndrome, and variants in CLCNKB result in classical Bartter syndrome. Although all variants impair TAL electrolyte transport, their effects on mineral handling differ. In contrast to antenatal forms, classical Bartter syndrome is frequently associated with hypomagnesemia, a feature also found in Gitelman syndrome resulting from pathogenic variants in SLC12A3, expressed in the distal convoluted tubule (DCT). The mechanisms underlying these distinct clinical phenotypes are not understood.
methodsClcnkb- and Slc12a3-deficient mice as well as human kidneys were investigated. The abundance and localization of electrolyte and mineral transporters and stereological parameters were assessed by immunohistochemistry. Gene and protein expression was determined in Clcnkb-deficient mice.
resultsIn human kidney, both ClC-K channels and their essential subunit Barttin were found in TAL, DCT, and collecting system. Clcnkb-deficient mice showed complete ablation of Clcnkb and reduced DCT and connecting tubule volumes. Furthermore, DCT magnesium channels and select basolateral magnesium transporters were markedly reduced in Clcnkb-deficient mice, similar to Slc12a3-deficient mice. In contrast, the overall abundance of calcium transport proteins was largely preserved.
conclusionClC-K channels are expressed in the TAL and DCT in mouse and human kidneys. Clcnkb ablation reduces TRPM magnesium channel expression and DCT tubule volume, providing a likely explanation for the frequently observed hypomagnesemia in classical Bartter syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.